Dementia with Lewy bodies presenting as probable epileptic seizure

Mya Z Tun1, Wee Kheng Soo2,3, Kevin Wu3

  • 1Geriatric Medicine, Monash Health, Victoria, Australia.

BMJ Case Reports
|September 29, 2017
PubMed

Insights

An 83-year-old man experienced altered consciousness, likely seizures, amidst cognitive decline. Advanced imaging supported a diagnosis of dementia with Lewy bodies (DLB), highlighting the need to consider comorbidities in elderly patients.

Area of Science:

  • Neurology
  • Geriatrics
  • Neuroimaging

Background:

  • Cognitive decline is common in the elderly, often presenting with acute changes in consciousness.
  • Differential diagnoses for altered consciousness in older adults typically include stroke and seizures.

Observation:

  • An 83-year-old male presented with recurrent episodes of altered consciousness and acute confusion, superimposed on a 6-year history of cognitive decline.
  • Initial investigations, including CT, MRI, and EEG, were negative for cerebrovascular accidents, epileptogenic foci, or epileptiform activity.

Findings:

  • A probable diagnosis of seizure in the context of dementia with Lewy bodies (DLB) was established.
  • Brain SPECT and FDG-PET imaging supported the diagnosis of DLB, indicating underlying neurodegenerative changes.

Implications:

  • This case underscores the importance of considering less common etiologies, such as dementia with Lewy bodies, in elderly patients presenting with altered consciousness.
  • Neuroimaging techniques like SPECT and PET can be crucial in diagnosing neurodegenerative conditions that may manifest with episodic neurological symptoms.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.8K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
597
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K